REGENXBIO Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $689.7M | $191.9M |
| Jun 2022 | — | $630.5M | $121.4M |
| Sep 2022 | — | $563.8M | $118.5M |
| Dec 2022 | — | $516.2M | $97.0M |
| Mar 2023 | — | $465.1M | $70.1M |
| Jun 2023 | — | $405.9M | $68.6M |
| Sep 2023 | — | $363.1M | $53.0M |
| Dec 2023 | — | $311.7M | $34.5M |
| Mar 2024 | — | $390.7M | $113.0M |
| Jun 2024 | — | $348.3M | $57.8M |
| Sep 2024 | — | $301.4M | $56.6M |
| Dec 2024 | — | $259.7M | $57.5M |
| Mar 2025 | — | $274.2M | $130.1M |
| Jun 2025 | — | $213.7M | $79.6M |
| Sep 2025 | — | $161.5M | $58.8M |
| Dec 2025 | — | $102.7M | $34.5M |
| Mar 2026 | — | $21.1M | $15.2M |
| Jun 2026 | — | $71.8M | $36.5M |